Skip to content
★ Sign in to follow
SM

SR Medical Technology Co. Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$9.2B

1 insider bought shares over the last 90 days, the latest by Wei Laier, filed 17 Sept 2026.

SR Medical Technology Co. Ltd.: what insiders have been doing

SR Medical Technology Co. Ltd. is a listed company. Its insiders report their share dealings to HKEX. From 19 October 2025 to 19 October 2026, the disclosure feed for SR Medical Technology Co. Ltd. logged 4 filings by 3 insiders.

On the market, 1 insider bought (1 purchase) while 1 insider sold (2 sales totalling €38.1M). The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €38.1M, sold by Wei Chunxian and made public on 19 November 2025. The buyers include 1 senior executive.

The clock since the last published purchase (17 September 2026) now reads 53 days. Typically, a trade is published a median of 21 days after it takes place. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

Compared with its exchange (1,323 companies, median 4 filings), a count of 4 filings is typical. The full history, which starts in 2017, counts 12 purchases against 13 sales.

This summary is built from HKEX disclosures alone and does not predict where the share price will go.

Insider Decl.
31
Thresholds
n/a
Buy Volume
€328M
12 ops. · all time
Sell Volume
€99M
13 ops. · all time

Who traded when

BuySale
Wei Chunxian3 sales
Wei Laier1 buy

Since the insiders bought

  • Filed 27 Jul 2018 · 3027 days ago · €8.2M
    +20.0%
    Entry HK$0.95 · Close at T+365 HK$1.14
  • Filed 14 Jun 2018 · 3070 days ago · €15.2M
    +73.5%
    Entry HK$0.83 · Close at T+365 HK$1.44

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 19,737 of 26,913 companies
35.7
score / 100
Value
36
Quality
36
FCF yld0.9%
Earn yld-1.3%
EV/EBITDA·
ROE-8.3%
Gross mgn64%
Net mgn-33%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$2.76
Analyst consensus
·
Income statement
RevenueHK$327.9M
Gross profitHK$209M64% margin
EBITDAHK$19.4M6% margin
Net income-HK$109.6M-47.9% margin
Valuation
P/Book9.0x
Beta-1.41
Balance sheet & cash
Market capHK$9.2B
Total debtHK$2.9B
Free Cash FlowHK$75.4M
Debt / Equity137%
Profitability & ownership
ROE-8.3%
ROA0.2%
% insiders58.9%
% institutions0.3%
Last declaration on 17 September 2026
Declarations31 total
  • ▲
    DirectorExecutives
    0HKEX
    53,000,000 sharesShareXHKGHKEX:DA20260916E00541
    Canonical exit: 10 Nov 2026 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    2,656,000 sharesShareXHKGHKEX:DA20260916E00542
  • ▼
    DirectorExecutives
    0HKEX
    53,000,000 sharesShareXHKGHKEX:DA20260916E00551
  • ▼
    DirectorExecutives
    344M HKD12HKEX
    430,000,000 shares@ HK$0.809.7% of flowShareXHKGHKEX:DA20251119E00160
  • ▼
    DirectorExecutives
    16M HKD11HKEX
    20,000,000 shares@ HK$0.800.5% of flowShareXHKGHKEX:DA20250117E00462
  • ●
    DirectorExecutives
    0HKEX
    2,776,738,877 sharesShareXHKGHKEX:DA20221122E00186
  • ●
    DirectorExecutives
    0HKEX
    8,669,925 sharesShareXHKGHKEX:DA20220105E00359
  • ▼
    DirectorExecutives
    9M HKD0HKEX
    7,500,000 shares@ HK$1.15ShareXHKGHKEX:DA20190507E00292
  • ▼
    DirectorExecutives
    6M HKD0HKEX
    7,500,000 shares@ HK$0.80ShareXHKGHKEX:DA20180903E00300
  • ▼
    DirectorExecutives
    0HKEX
    164,728,575 sharesShareXHKGHKEX:DA20180821E00043
  • ▲
    DirectorExecutives
    0HKEX
    5,020,500 sharesShareXHKGHKEX:DA20180727E00064
    Canonical exit: 22 Oct 2018 (T+90)
  • ▼
    DirectorExecutives
    0HKEX
    269,509,010 sharesShareXHKGHKEX:DA20180727E00054
  • ▲
    DirectorExecutives
    75M HKD0HKEX
    93,826,063 shares@ HK$0.80ShareXHKGHKEX:DA20180727E00053
    Canonical exit: 22 Oct 2018 (T+90)
  • ▼
    DirectorExecutives
    1M HKD0HKEX
    1,816,000 shares@ HK$0.79ShareXHKGHKEX:DA20180706E00290
  • ▲
    DirectorExecutives
    0HKEX
    5,000,000 sharesShareXHKGHKEX:DA20180622E00218
    Canonical exit: 18 Sept 2018 (T+90)
  • ▲
    DirectorExecutives
    1,600 HKD0HKEX
    2,000 shares@ HK$0.80ShareXHKGHKEX:DA20180614E00173
    Canonical exit: 10 Sept 2018 (T+90)
  • ▲
    DirectorExecutives
    572,800 HKD0HKEX
    716,000 shares@ HK$0.80ShareXHKGHKEX:DA20180614E00172
    Canonical exit: 9 Sept 2018 (T+90)
  • ▲
    DirectorExecutives
    139M HKD0HKEX
    173,398,500 shares@ HK$0.80ShareXHKGHKEX:DA20180614E00178
    Canonical exit: 28 Aug 2018 (T+90)
  • ▲
    DirectorExecutives
    1B HKD0HKEX
    1,753,251,500 shares@ HK$0.80ShareXHKGHKEX:DA20180614E00167
    Canonical exit: 28 Aug 2018 (T+90)
  • ▲
    DirectorExecutives
    75M HKD0HKEX
    93,826,063 shares@ HK$0.80ShareXHKGHKEX:DA20180614E00166
    Canonical exit: 22 Aug 2018 (T+90)
  • ▲
    DirectorExecutives
    654M HKD0HKEX
    817,106,599 shares@ HK$0.80ShareXHKGHKEX:DA20180614E00163
    Canonical exit: 22 Aug 2018 (T+90)
  • ▼
    DirectorExecutives
    179M HKD0HKEX
    179,484,147 shares@ HK$1.00ShareXHKGHKEX:DA20180226E00170
  • ▼
    DirectorExecutives
    179M HKD0HKEX
    179,484,147 shares@ HK$1.00ShareXHKGHKEX:DA20180226E00168
  • ●
    DirectorExecutives
    87M HKD0HKEX
    95,446,723 shares@ HK$0.91ShareXHKGHKEX:DA20180119E00604
  • ▼
    DirectorExecutives
    180M HKD0HKEX
    150,000,000 shares@ HK$1.20ShareXHKGHKEX:DA20171221E00127

25 of 31 declarations

About SR Medical Technology Co. Ltd.

SR Medical Technology Co. Ltd. is a company specializing in the development and manufacturing of innovative medical devices. It focuses on improving healthcare through advanced technologies.